US 8669258
Treatment for gastroparesis using sepiapterin
granted A61KA61K31/4985A61K31/519
Quick answer
US patent 8669258 (Treatment for gastroparesis using sepiapterin) held by The Board of Regents of the University of Texas System expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4985, A61K31/519, A61K45/06, A61P